Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
391.4000 -5.90 (-1.49%)
NSE Jul 31, 2025 15:31 PM
Volume: 2.9M
 

logo
Biocon Ltd.
13 Jan 2025
391.40
-1.49%
Motilal Oswal
Biocon (BIOS) has received ‘Voluntary Action Indicated’ (VAI) status for its Malaysian site. With this, BIOS now has all critical sites for biosimilars under USFDA compliance, improving its business prospects in the US market.
Number of FII/FPI investors increased from 305 to 333 in Jun 2025 qtr.
More from Biocon Ltd.
Recommended